BPTH
Income statement / Annual
Last year (2023), Bio-Path Holdings, Inc.'s total revenue was $0.00,
and the percentage change from the previous year is not available.
In 2023, Bio-Path Holdings, Inc.'s net income was -$16.08 M.
See Bio-Path Holdings, Inc.,s key income statements, including revenue, expenses, profit, and income.
Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
FY-2014
|
Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
12/31/2014 |
Operating Revenue |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$37,000.00 |
$13,000.00 |
$0.00 |
$0.00 |
Cost of Revenue |
$178,000.00
|
$178,000.00
|
$161,000.00
|
$151,000.00
|
$230,000.00
|
$426,000.00
|
$0.00
|
$0.00
|
$201,762.00
|
$0.00
|
Gross Profit |
-$178,000.00
|
-$178,000.00
|
-$161,000.00
|
-$151,000.00
|
-$230,000.00
|
-$426,000.00
|
$37,000.00
|
$13,000.00
|
-$201,762.00
|
$0.00
|
Gross Profit Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
0
|
0
|
Research and Development Expenses |
$11.61 M
|
$9.17 M
|
$5.91 M
|
$6.58 M
|
$4.59 M
|
$4.60 M
|
$5.48 M
|
$5.47 M
|
$3.02 M
|
$1.83 M
|
General & Administrative Expenses |
$4.11 M
|
$4.74 M
|
$4.53 M
|
$4.33 M
|
$4.11 M
|
$3.38 M
|
$3.52 M
|
$3.01 M
|
$2.46 M
|
$2.72 M
|
Selling & Marketing Expenses |
$123,000.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
Selling, General & Administrative Expenses |
$4.24 M
|
$4.74 M
|
$4.53 M
|
$4.33 M
|
$4.11 M
|
$3.38 M
|
$3.52 M
|
$3.01 M
|
$2.46 M
|
$2.72 M
|
Other Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$608,000.00
|
$0.00
|
$0.00
|
$196,661.00
|
$0.00
|
Operating Expenses |
$15.84 M
|
$13.90 M
|
$10.44 M
|
$10.91 M
|
$8.69 M
|
$7.98 M
|
$9.00 M
|
$8.49 M
|
$5.48 M
|
$4.54 M
|
Cost And Expenses |
$15.84 M
|
$13.90 M
|
$10.44 M
|
$10.91 M
|
$8.69 M
|
$7.98 M
|
$9.00 M
|
$8.49 M
|
$5.48 M
|
$4.54 M
|
Interest Income |
$36,000.00
|
$33,000.00
|
$3,000.00
|
$26,000.00
|
$94,000.00
|
$7,000.00
|
$9,000.00
|
$12,000.00
|
$17,665.00
|
$22,632.00
|
Interest Expense |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
Depreciation & Amortization |
$82,000.00
|
$178,000.00
|
$161,000.00
|
$151,000.00
|
$230,000.00
|
$426,000.00
|
$411,000.00
|
$204,000.00
|
$201,762.00
|
$170,909.00
|
EBITDA |
-$15.76 M |
-$13.69 M |
-$10.28 M |
-$10.73 M |
-$8.37 M |
-$8.16 M |
-$8.56 M |
-$8.27 M |
-$5.27 M |
-$4.35 M |
EBITDA Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
-283.49
|
-768
|
0
|
0
|
Operating Income Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
-242.32
|
-651.92
|
0
|
0
|
Total Other Income/Expenses Net |
-$235,000.00
|
$33,000.00
|
$3,000.00
|
$26,000.00
|
$94,000.00
|
$7,000.00
|
$1.94 M
|
$1.73 M
|
$18,206.00
|
$22,051.00
|
Income Before Tax |
-$16.08 M
|
-$13.87 M
|
-$10.44 M
|
-$10.88 M
|
-$8.60 M
|
-$8.58 M
|
-$7.02 M
|
-$6.75 M
|
-$5.47 M
|
-$4.52 M
|
Income Before Tax Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
-189.81
|
-519.23
|
0
|
0
|
Income Tax Expense |
$0.00
|
-$33,000.00
|
-$3,000.00
|
-$26,000.00
|
-$94,000.00
|
-$608,000.00
|
-$1.94 M
|
-$1.73 M
|
$0.00
|
-$22,297.00
|
Net Income |
-$16.08 M
|
-$13.84 M
|
-$10.44 M
|
-$10.86 M
|
-$8.51 M
|
-$8.58 M
|
-$7.02 M
|
-$6.75 M
|
-$5.47 M
|
-$4.52 M
|
Net Income Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
-189.81
|
-519.23
|
0
|
0
|
EPS |
-33.64 |
-38.03 |
-31.04 |
-56.44 |
-64.02 |
-287.54 |
-278.69 |
-291.26 |
-243.61 |
-202.5 |
EPS Diluted |
-33.64 |
-38.03 |
-31.04 |
-56.44 |
-64.02 |
-287.54 |
-278.69 |
-291.26 |
-243.61 |
-202.5 |
Weighted Average Shares Out |
$478,000.00
|
$363,800.00
|
$336,250.00
|
$192,350.00
|
$132,850.00
|
$29,850.00
|
$25,200.00
|
$23,175.00
|
$22,440.75
|
$22,320.50
|
Weighted Average Shares Out Diluted |
$478,000.00
|
$363,800.00
|
$336,250.00
|
$192,350.00
|
$132,850.00
|
$29,850.00
|
$25,200.00
|
$23,175.00
|
$22,440.75
|
$22,320.50
|
Link |
|
|
|
|
|
|
|
|
|
|